Getinge Group Interim report January – June 2014

Reporting period January – June

  · Order intake rose 1.2% to SEK 12,628 M (12,483), and declined 0.1%
organically
  · Net sales increased by 2.4% to SEK 11,959 M (11,680), and grew 1.0%
organically
  · The result before tax declined 89.0% to SEK 97 M (878)
  · Net profit declined 88.9% to SEK 71 M (641)
  · Earnings per share declined 89.1% to SEK 0.29 (2,67)
  · EBITA before restructuring costs declined 12.4% to SEK 1,575 M (1,797)
  · Cash flow from operating activities increased 10.8% to SEK 1,339 M (1,209)

Reporting period April – June

  · Order intake rose 2.1% to SEK 6,651 M (6,515), and declined 0.5% organically
  · Net sales increased by 5.2 % to SEK 6,327 M (6,016), and grew 2.3%
organically
  · The result before tax declined 12.3% to SEK 549 M (626)
  · EBITA before restructuring costs declined 9.9% to SEK 905 M (1,004)

Second quarter of 2014

Despite a challenging quarter, the Group takes a confident view of the future.
The weak demand situation experienced in the emerging markets at the beginning
of the year is expected to improve during the remainder of the year. Specific
action plans are in place to address the areas that are obstructing profit
development: the quality management system within Medical Systems, a ventilator
offering adapted to the needs of the emerging markets, and an adaptation of TSS
(Therapeutic Support Systems) to prevailing market conditions. In addition to
these short-term priorities, there are favorable opportunities to enhance the
efficiency of the business and strengthen profitability in the medium term.

Teleconference with CEO Johan Malmquist and CFO Ulf Grunander

15 July 2014 at 10:00 a.m. Swedish time
Sweden: +46 (0) 8 5065 3938
UK: +44 (0) 20 3427 1907
US: +1 646 254 3365
Code: 9813592